In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that event, which is intended to provide an overview of activities currently underway worldwide to make BNCT available for patient treatments.

Author:

Prof. Dr. Wolfgang Sauerwein
wolfgang.sauerwein@uni-due.de

Published Online: 26 Dez 2022

Link: http://doi.org/10.1089/cbr.2022.0072

To cite this article:
Wolfgang A.G. Sauerwein and Miha Ulčar
Overview of Boron Neutron Capture Therapy in 2022
Cancer Biotherapy and Radiopharmaceuticals
ahead of print
http://doi.org/10.1089/cbr.2022.0072

Abstract:

In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that event, which is intended to provide an overview of activities currently underway worldwide to make BNCT available for patient treatments. This overview does not claim to be exhaustive but shows a great deal of activity in all areas necessary for the complex therapy that is BNCT. A rapid increase in the number of BNCT centers can be expected over the next few years, coupled with the introduction of novel drugs for BNCT. It will be a major challenge to all stakeholders to create clinical networks that can conduct the necessary prospective clinical trials in a short time and in high quality.